MG
WVE icon

Michael Gelband’s Wave Life Sciences WVE Stock Holding History

Michael Gelband’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
+251,072
New +$1.66M 0.01% 956
2025
Q4 		– Sell
-94,080
Closed -$689K – 2135
2025
Q3 		$689K Buy
94,080
+83,816
+817% +$678K 0.01% 1084
2025
Q2 		$67K Sell
10,264
-86,004
-89% -$568K ﹤0.01% 1368
2025
Q1 		$778K Buy
+96,268
New +$1.05M 0.01% 988
2021
Q4 		– Sell
-18,381
Closed -$90K – 2653
2021
Q3 		$90K Sell
18,381
-48,797
-73% -$296K ﹤0.01% 1919
2021
Q2 		$447K Buy
+67,178
New +$439K ﹤0.01% 1516
2021
Q1 		– Sell
-36,793
Closed -$290K – 2675
2020
Q4 		$290K Sell
36,793
-64,994
-64% -$546K ﹤0.01% 1557
2020
Q3 		$864K Buy
101,787
+55,024
+118% +$603K 0.02% 749
2020
Q2 		$487K Buy
+46,763
New +$440K 0.01% 1101
2019
Q3 		– Sell
-18,650
Closed -$487K – 1681
2019
Q2 		$487K Buy
+18,650
New +$523K 0.02% 488

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Michael Gelband's WVE Position: Q2 2026 in Review

Michael Gelband opened a new position in Wave Life Sciences (WVE) in Q2 2026: 251,072 shares worth $1.46M. The stake represents 0.01% of the portfolio and ranks #956 among its holdings. This is a return to the name: Michael Gelband previously reported a position in WVE as recently as Q3 2025.

Michael Gelband first reported a position in WVE in Q2 2019 and has held it in 10 quarters since. 238 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Michael Gelband held 251,072 shares of Wave Life Sciences worth $1.46M as of Q2 2026.
  • Wave Life Sciences was a new Michael Gelband position in Q2 2026.
  • Wave Life Sciences made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #956 holding.
  • Michael Gelband first reported a position in Wave Life Sciences in Q2 2019 and has held it in 10 quarters since.
  • 238 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.